LENZ THERAPEUTICS INC (LENZ) Stock Balance Sheet
NASDAQ:LENZ - US52635N1037 - Common Stock
38.63 USD
+0.43 (+1.13%)
39.25 USD
+0.62 (+1.6%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.61M | 20.16M | 184.26M | 47.70M | 377.00M | |||
| Marketable Securities | 171.91M | 188.87M | 0.00 | 220.50M | N/A | |||
| Other Current Assets | 4.08M | 2.89M | 3.76M | 7.10M | 4.80M | |||
| Total Current Assets | 213.60M | 211.92M | 188.02M | 275.40M | 381.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.13M | 1.99M | 321.00K | 28.20M | 18.10M | |||
| Investments And Advances | N/A | N/A | 0.00 | 15.30M | N/A | |||
| Other Non-Current Assets | 1.60M | 1.40M | 114.00K | 3.00M | 2.20M | |||
| Total Non-Current Assets | 3.73M | 3.39M | 435.00K | 46.50M | 20.30M | |||
| TOTAL ASSETS | 217.33M | 215.30M | 188.46M | 321.90M | 402.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.54M | 6.15M | 4.55M | 10.40M | 9.70M | |||
| Accounts Payable | 2.85M | 4.26M | 250.00K | 2.60M | 2.50M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 10.40M | 10.41M | 4.80M | 13.00M | 12.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 569.00K | 814.00K | 77.00K | 12.60M | 5.80M | |||
| Total Non-Current Liabilities | 569.00K | 814.00K | 77.00K | 12.60M | 5.80M | |||
| TOTAL LIABILITIES | 10.97M | 11.22M | 4.87M | 25.60M | 17.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -174.54M | -145.01M | -367.05M | -242.40M | -141.40M | |||
| Additional Paid In Capital | 380.87M | 348.90M | 550.63M | 539.70M | 525.40M | |||
| Common Shares | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 38.00K | 196.00K | 0.00 | -1.00M | N/A | |||
| Shares Outstanding | 28.50M | 27.52M | 8.29M | 58.20M | 58.00M | |||
| Tangible Book Value per Share | 7.24 | 7.42 | 22.15 | 5.09 | 6.62 | |||
| Total Shareholders' Equity | 206.37M | 204.08M | 183.58M | 296.30M | 384.10M | |||
| TOTAL LIABILITIES AND EQUITY | 217.33M | 215.30M | 188.46M | 321.90M | 402.00M | |||
| Statistics | ||||||||
| Current Ratio | 20.54 | 20.36 | 39.20 | 21.18 | 31.55 | |||
| Return On Assets (ROA) | -24.11% | -23.12% | -66.14% | -31.39% | -17.60% | |||
| Return On Equity (ROE) | -25.39% | -24.39% | -67.90% | -34.10% | -18.42% | |||
All data in USD , ROIC based on taxRate of 0.21